These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32875426)

  • 21. AGO CLIP-based imputation of potent siRNA sequences targeting SARS-CoV-2 with antifibrotic miRNA-like activity.
    Ahn SH; Gu D; Koh Y; Lee HS; Chi SW
    Sci Rep; 2021 Sep; 11(1):19161. PubMed ID: 34580386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging plasticity of SARS-CoV-2.
    McCormick KD; Jacobs JL; Mellors JW
    Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
    [No Abstract]   [Full Text] [Related]  

  • 23. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNAi to treat SARS-CoV-2-variant proofing the next generation of therapies.
    McMillan NAJ; Morris KV; Idris A
    EMBO Mol Med; 2022 Apr; 14(4):e15811. PubMed ID: 35285158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2.
    Rodríguez-Grande C; Adán-Jiménez J; Catalán P; Alcalá L; Estévez A; Muñoz P; Pérez-Lago L; García de Viedma D
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus.
    O'Leary VB; Dolly OJ; Höschl C; Černa M; Ovsepian SV
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans.
    Rudd JM; Tamil Selvan M; Cowan S; Kao YF; Midkiff CC; Narayanan S; Ramachandran A; Ritchey JW; Miller CA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The coding capacity of SARS-CoV-2.
    Finkel Y; Mizrahi O; Nachshon A; Weingarten-Gabbay S; Morgenstern D; Yahalom-Ronen Y; Tamir H; Achdout H; Stein D; Israeli O; Beth-Din A; Melamed S; Weiss S; Israely T; Paran N; Schwartz M; Stern-Ginossar N
    Nature; 2021 Jan; 589(7840):125-130. PubMed ID: 32906143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basic information of Coronavirus].
    Kamitani W
    Uirusu; 2020; 70(1):29-36. PubMed ID: 33967109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2: March toward adaptation.
    Benedetti F; Pachetti M; Marini B; Ippodrino R; Ciccozzi M; Zella D
    J Med Virol; 2020 Nov; 92(11):2274-2276. PubMed ID: 32598499
    [No Abstract]   [Full Text] [Related]  

  • 31. Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies.
    Lau BT; Pavlichin D; Hooker AC; Almeda A; Shin G; Chen J; Sahoo MK; Huang CH; Pinsky BA; Lee HJ; Ji HP
    Genome Med; 2021 Apr; 13(1):62. PubMed ID: 33875001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential mutation profile of SARS-CoV-2 proteins across deceased and asymptomatic patients.
    Laskar R; Ali S
    Chem Biol Interact; 2021 Sep; 347():109598. PubMed ID: 34303694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells.
    Han Q; Wang J; Luo H; Li L; Lu X; Liu A; Deng Y; Jiang Y
    Aging (Albany NY); 2021 Mar; 13(7):9160-9185. PubMed ID: 33744846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic sequencing effort for SARS-CoV-2 by country during the pandemic.
    Furuse Y
    Int J Infect Dis; 2021 Feb; 103():305-307. PubMed ID: 33333251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Audio Interview: The Omicron Variant of SARS-CoV-2.
    Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
    N Engl J Med; 2021 Dec; 385(23):e96. PubMed ID: 34874638
    [No Abstract]   [Full Text] [Related]  

  • 36. A small interfering RNA (siRNA) database for SARS-CoV-2.
    Medeiros IG; Khayat AS; Stransky B; Santos S; Assumpção P; de Souza JES
    Sci Rep; 2021 Apr; 11(1):8849. PubMed ID: 33893357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the rationale for thermotherapy in COVID-19.
    Mancilla-Galindo J; Galindo-Sevilla N
    Int J Hyperthermia; 2021; 38(1):202-212. PubMed ID: 33682604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origins of SARS-CoV-1 and SARS-CoV-2 are often poorly explored in leading publications.
    Wenzel J
    Cladistics; 2020 Aug; 36(4):374-379. PubMed ID: 34618963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection.
    Gerber PP; Duncan LM; Greenwood EJ; Marelli S; Naamati A; Teixeira-Silva A; Crozier TW; Gabaev I; Zhan JR; Mulroney TE; Horner EC; Doffinger R; Willis AE; Thaventhiran JE; Protasio AV; Matheson NJ
    PLoS Pathog; 2022 Feb; 18(2):e1010265. PubMed ID: 35143592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?
    Panda K; Alagarasu K; Tagore R; Paingankar M; Kumar S; Jeengar MK; Cherian S; Parashar D
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.